Clinical Trial: Quality of Life, Safety and Compliance of Patients Using Monotherapy or Combinatorial Therapy With Quetiapine for Treatment of Schizophrenia or Bipolar Affective Disorder

U.S., Oct. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07858565) titled 'Quality of Life, Safety and Compliance of Patients Using Monotherapy or Combinatorial Therapy With Quetiapine for Treatment of Schizophrenia or Bipolar Affective Disorder' on Sept. 29.

Brief Summary: The goal of this observational study is to evaluate the quality of life, drug safety and therapy compliance of schizophrenia or bipolar affective disorder patients during the treatment with quetiapine monotherapy or in combination with another antipsychotic/antipsychotics. The main outcome measures are:

* quality of life using the World Health Organization Quality of Life questionnaire (WHOQOL)

* safety through the monitoring of the in...